Last checked at 
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:
----------
Umuthi Healthcare Solutions PLC - South Africa-based technology-led healthcare - Hires Phillip Van Huyssteen as chief financial officer, replacing Pieter Grimes, who is leaving "to pursue other business opportunities". Van Huyssteen was CFO of Africa Healthcare Hospital Group which was later acquired by Johannesburg-listed RH Bophelo Ltd. Umuthi shares remain suspended from trading in London. Back in June, the stock was ordered suspended by the UK Financial Conduct Authority for the second time since its initial public offering in March, over concerns about the ability to trade some shares in involved in a share exchange agreement.
----------
Liontrust Asset Management PLC - London-based specialist fund manager - Senior Independent Director Mike Bishop will step down from the board at the company's annual general meeting on September 23, having served for 10 years. Sophia Ticknell will step down as independent non-executive director at the same time, having been on the board for four years. Liontrust says it will make a further announcement on a replacement senior independent director and the recruitment of a new non-executive director.
----------
Verici Dx PLC - Cardiff-based firm developing and commercialising tests of response to organ transplant, initially focused on kidney transplants - Hires Lorenzo Gallon as non-executive director, effective immediately. Gallon is a professor of Medicine, Nephrology & Hypertension, and Surgery, Organ Transplantation. He is the medical director of the Translational Medicine Program, the director of International Relations, and the director of the Renal Transplant Fellowship at Northwestern University in Chicago. Back in March Verici Dx partnered with Gallon on the first US clinical trials for its two lead products, Clarava and Tuteva.
----------
Nanoco Group PLC - Manchester-based developer and manufacturer of cadmium-free quantum dots for displays and electronics - Appoints Henry Turcan as non-executive director, starting September 1. Turcan is a fund manager at Lombard Odier Asset Management (Europe) Ltd, Nanoco's largest shareholder, with a 27% stake. Turcan, who is an adviser to and investor in UK smaller companies, has no personal stake in Nanoco.
----------
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
